Welcome to our dedicated page for Benefitfocus news (Ticker: BNFT), a resource for investors and traders seeking the latest updates and insights on Benefitfocus stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Benefitfocus's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Benefitfocus's position in the market.
Benefitfocus, Inc. (NASDAQ: BNFT) reported Q1 2020 financial results highlighting a 3% decline in total revenue to $66.2 million. Despite challenges, net loss improved to $11.1 million from $14.2 million year-over-year. The company expanded its net benefit eligible lives to 17.5 million and launched several initiatives, including launching benefitplace.com and the Community Resource Center. Adjusted EBITDA rose to $4.1 million. The guidance for Q2 2020 projects revenue between $55.0 million and $58.0 million, with a non-GAAP net loss expected between $9.0 million to $7.0 million.
Summary not available.